References

  1. Zamora AC, Collard HR, Wolters PJ et al. Neurofibromatosis-associated lung disease: a case series and literature review. European Respiratory Journal. 2007; 29(1): 210-214. PubMed | Google Scholar

  2. Pinson S, Créange A, Barbarot S et al. Recommendations for the treatment of neurofibromatosis type 1. J Fr Ophtalmol. 2002 Apr;25(4):423-33. PubMed | Google Scholar

  3. Revion-rabec L, Girerd B, Seferian A et al. Pulmonary complications of type 1 neurofibromatosis. Revue des maladies respiratoires. 2016 Jun;33(6):460-73. Google Scholar

  4. Ryu JH, Beert E, De Ravel T et al. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009 May;10(5):508-15. Google Scholar

  5. Reubi F. Neurofibromatosis and vascular lesions. Schweiz Med Wochenschr. 1945;75:463-46. Google Scholar

  6. Bassou D, Darbia A, Atmanea M et al. Ectasic diffuse vasculopathy of the cerebral arteries associated with neurofibromatosis type 1. J Neuroradiol. 2008 Dec;35(5):292-6. PubMed | Google Scholar

  7. Hongsakul K, Rookkapan S, Tanutit P et al. Sponatneous massive hemothorax in a patient with neurofibromatos type 1 with successful transartériel embolisation. Korean J Radiol. 2013;14(1):86-90. Google Scholar

  8. Montani D, Coulet F, Girerd B et al. Pulmonary Hypertension in Patients With Neurofibromatosis Type I. Medicine. May 2011; 90(3): 201-211. PubMed | Google Scholar

  9. Martignac F, Gagnadoux W, Trzepizur et al. Severe pulmonary involvement in the course of type 1 neurofibromatosis. Rev Mal Respir. 2014 Sep;31(7):621-3. Google Scholar